• bitcoinBitcoin(BTC)$78,178.000.06%
  • ethereumEthereum(ETH)$2,295.671.04%
  • tetherTether(USDT)$1.00-0.05%
  • binancecoinBNB(BNB)$709.01-0.58%
  • rippleXRP(XRP)$1.250.05%
  • usd-coinUSDC(USDC)$1.00-0.04%
  • solanaSolana(SOL)$94.65-1.00%
  • tronTRON(TRX)$0.3156481.71%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.080.00%
  • zcashZcash(ZEC)$1,258.000.72%
  • HyperliquidHyperliquid(HYPE)$86.54-1.23%
  • dogecoinDogecoin(DOGE)$0.075490-0.41%
  • moneroMonero(XMR)$606.600.40%
  • USDSUSDS(USDS)$1.00-0.08%
  • whitebitWhiteBIT Coin(WBT)$75.220.24%
  • chainlinkChainlink(LINK)$11.32-3.60%
  • leo-tokenLEO Token(LEO)$9.40-0.05%
  • cardanoCardano(ADA)$0.191557-0.86%
  • stellarStellar(XLM)$0.167916-0.67%
  • bitcoin-cashBitcoin Cash(BCH)$277.66-2.25%
  • nearNEAR Protocol(NEAR)$4.14-5.50%
  • daiDai(DAI)$1.00-0.05%
  • uniswapUniswap(UNI)$7.25-0.29%
  • Ethena USDeEthena USDe(USDE)$1.00-0.05%
  • litecoinLitecoin(LTC)$55.19-1.74%
  • RainRain(RAIN)$0.006008-0.24%
  • USD1USD1(USD1)$1.00-0.04%
  • avalanche-2Avalanche(AVAX)$8.61-2.14%
  • CantonCanton(CC)$0.095065-2.36%
  • suiSui(SUI)$0.89-1.45%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.20-1.53%
  • hedera-hashgraphHedera(HBAR)$0.071257-0.88%
  • tether-goldTether Gold(XAUT)$3,894.630.59%
  • Global DollarGlobal Dollar(USDG)$1.00-0.03%
  • quant-networkQuant(QNT)$197.91-0.99%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.05%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.00%
  • BittensorBittensor(TAO)$230.37-3.04%
  • crypto-com-chainCronos(CRO)$0.051084-0.75%
  • Ripple USDRipple USD(RLUSD)$1.00-0.05%
  • EthenaEthena(ENA)$0.180309-4.43%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.04%
  • okbOKB(OKB)$113.121.83%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • pepePepe(PEPE)$0.000005-2.23%
  • aaveAave(AAVE)$132.45-3.14%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • MemeCoreMemeCore(M)$0.863.72%
  • OndoOndo(ONDO)$0.397161-3.52%
  • Pump.funPump.fun(PUMP)$0.004110-3.07%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Pfizer, Moderna shares plunge on report that Trump officials plan to link child deaths to COVID vaccine

September 12, 2025
in Business
Reading Time: 3 mins read
A A
Pfizer, Moderna shares plunge on report that Trump officials plan to link child deaths to COVID vaccine
ShareShareShareShareShare

Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines.

YOU MAY ALSO LIKE

Binance withdrawals spike as it returns online after $6.3B heist

OPEC+ keeps December oil output targets steady ahead of tougher call for 2027

Trump health officials plan to include the claim in a presentation next week to a panel of advisors to the CDC that is considering new COVID vaccine recommendations, which can impact access to the shots and whether they’re free, according to the Washington Post.

Those deaths were seemingly gathered from information submitted to the government’s Vaccine Adverse Event Reporting System, according to the report.

The Trump administration plans to link the deaths of 25 children to COVID vaccines, according to a report. REUTERS

VAERS contains unverified reports of side effects from vaccines, which can be submitted from anyone like patients and doctors to pharmacists or even someone who sees a story on social media.

The system is not meant to actually verify whether an immunization caused a death.

The presentation is not yet final, a person familiar with the matter told the Washington Post.

“FDA and CDC staff routinely analyze VAERS and other safety monitoring data, and those reviews are being shared publicly through the established ACIP process,” Andrew Nixon, communications director of the Health and Human Services Department, told The Post.

“Until that is shared publicly, any of this should be considered pure speculation.”

Moderna and Pfizer did not immediately respond to The Post’s requests for comment.

Trump health officials plan to include the claim in a presentation next week, according to the Washington Post. AFP via Getty Images

The vaccine advisory panel’s meeting next week is crucial, as it will help determine whether insurers must pay for the vaccines, as well as whether pharmacies can administer them and doctors are willing to offer them at their practices.

Health and Human Services Secretary Robert F. Kennedy Jr. – who was recently grilled by senators from both parties at a tense hearing on vaccines – ousted every member of the vaccine panel earlier this year and replaced them with his own picks. 

Health officials’ planned presentation for next week included attempts to interview some families, though it’s unclear what other information was used in preparation, according to the report.

In May, Kennedy ordered health officials to stop recommending the shots for healthy children, saying only people at high risk of complications from COVID or over age 65 need them.

In May, Kennedy ordered health officials to stop recommending the shots for healthy children. REUTERS

The health agency also cancelled nearly $500 million in research funding on mRNA vaccines.

The CDC later advised parents to consult a doctor before getting their children vaccinated. 

Several top officials at the CDC resigned in late August, claiming that Kennedy has ignored established research and politicized vaccine safety.

The American Academy of Pediatrics recommends annual COVID vaccines for children ages 6 to 23 months, and for older children, adding that the shots are safe and effective in protecting against serious outcomes.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Binance withdrawals spike as it returns online after .3B heist
Business

Binance withdrawals spike as it returns online after $6.3B heist

November 1, 2026
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027
Business

OPEC+ keeps December oil output targets steady ahead of tougher call for 2027

November 1, 2026
Global law firm Vedder getting new NYC digs with move to Sixth Ave. tower
Business

Global law firm Vedder getting new NYC digs with move to Sixth Ave. tower

November 1, 2026
Jean-Georges Vongerichten launching 3 dining concepts at Hudson Yards
Business

Jean-Georges Vongerichten launching 3 dining concepts at Hudson Yards

November 1, 2026
Next Post
Rockwell Automation: Structural Tailwinds, But With A Stretched Valuation (NYSE:ROK)

Rockwell Automation: Structural Tailwinds, But With A Stretched Valuation (NYSE:ROK)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Vanity Fair stays mum despite facing lawsuit over explosive article claiming Jared Kushner oversaw secret Saudi, UAE slush fund

Vanity Fair stays mum despite facing lawsuit over explosive article claiming Jared Kushner oversaw secret Saudi, UAE slush fund

October 26, 2026
Making ,958 in 20 mins

Making $1,958 in 20 mins

October 26, 2026
Bari Weiss and ’60 Minutes’ boss weren’t briefed on deportee’s ‘gay’ asylum claim ahead of controversial segment: sources

Bari Weiss and ’60 Minutes’ boss weren’t briefed on deportee’s ‘gay’ asylum claim ahead of controversial segment: sources

October 30, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!